Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data. At OptimizeRx, we’re applying this...
Despite incredible advances in the availability of real-world data (RWD) and AI applications, many tech-savvy brand...
At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to present on how...
In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored three key areas...
In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...
In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier, which is...
Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies into a true...
An astounding 7,000 rare and orphan diseases affect more than 30 million people in the United States alone1. Rare diseases are classified as any disease that affects less...
As the coronavirus (COVID-19) spread across the nation, greatly impacting people’s health and lives, trustworthy and relevant health information from a reliable source became...
The annual meeting of the American Society of Clinical Oncology (ASCO) was held last month and I am excited to share with you my thoughts on the highlights from this year’s...
I recently had the honor of speaking at Momentum Events Decoding Digital Health for Life Sciences, on the value and benefits of SMS text-based patient engagement programs. I...
As a scientist, I know first-hand how much time and energy go into the drug discovery and development process from day one. In fact, one of the highlights of my research...
